Method for providing textile material with UV protection

Details for Australian Patent Application No. 2002238531 (hide)

Owner BASF AKTIENGESELLSCHAFT

Inventors Wagenblast, Gerhard; Heidenfelder, Thomas; Detering, Jurgen

Agent Watermark

Pub. Number AU-A-2002238531

PCT Pub. Number WO2002/063091

Priority 101 05 143.3 06.02.01 DE

Filing date 5 February 2002

Wipo publication date 19 August 2002

International Classifications

D06M 011/44 Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with inorganic substances or complexes thereof

D06M 013/224 Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials with non-macromolecular organic compounds

D06M 013/35 Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials with non-macromolecular organic compounds

D06M 013/12 Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials with non-macromolecular organic compounds

D06M 011/46 Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with inorganic substances or complexes thereof

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002238531

24 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002238532-TRIPEPTIDE DERIVATIVES FOR THE TREATMENT OF POSTLESIONAL DISEASES OF THE NERVOUS SYSTEM

2002238530-Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity